Anders Wimo

MedicineEconomics, Econometrics and FinanceHealth ProfessionsSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint”.

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2023.100657

N/A

0.724DataRank · unranked

124 citations

Anders Wimo, Ron Handels, Gunilla Johansson, Mercè Boada, Sebastiaan Engelborghs +11 more

IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease

Value in Health(2024)10.1016/j.jval.2024.09.006

N/A

0.241DataRank · unranked

4 citations

William L. Herring, F. Kamgar, Sandar Aye, Ashley Tate, Colin Green +18 more